Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2002
10/03/2002WO2002076986A1 Pyrazolopyrimidines as therapeutic agents
10/03/2002WO2002076983A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors
10/03/2002WO2002076982A2 Non-nucleoside reverse transcriptase inhibitors
10/03/2002WO2002076980A1 Sialic acid derivatives
10/03/2002WO2002076979A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
10/03/2002WO2002076977A2 Rho-kinase inhibitors
10/03/2002WO2002076976A2 Rho-kinase inhibitors
10/03/2002WO2002076975A1 Chemical derivatives and their use as anti-telomerase agent
10/03/2002WO2002076973A1 N-aryl-substituted cyclic amine derivative and medicine containing the same as active ingredient
10/03/2002WO2002076964A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
10/03/2002WO2002076959A1 Five-membered heterocyclic alkanoic acid derivative
10/03/2002WO2002076957A1 Activator for peroxisome proliferator-activated receptor
10/03/2002WO2002076951A1 2-mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors
10/03/2002WO2002076950A2 Imidiazole derivatives and their use as agonists selective at alpha 2b or 2b/2c adrenergic receptors
10/03/2002WO2002076949A1 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
10/03/2002WO2002076948A1 Novel piperidine derivatives as modulators of chemokine receptors
10/03/2002WO2002076947A1 Mch antagonists and their use in the treatment of obesity
10/03/2002WO2002076945A1 Aminopyrrolidine sulfonamides as serine protease inhibitors
10/03/2002WO2002076935A1 Novel a-lipoic acid derivative and use thereof
10/03/2002WO2002076933A1 Formailide derivatives as beta2-adrenoreceptor agonists
10/03/2002WO2002076930A2 Substituted diarylureas as stimulators for fas-mediated apoptosis
10/03/2002WO2002076929A1 Aryl and biaryl compounds having mch modulatory activity
10/03/2002WO2002076926A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/03/2002WO2002076925A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/03/2002WO2002076509A2 Preparation for the prophylaxis of restenosis
10/03/2002WO2002076505A1 Remedies for post-traumatic stress disorder
10/03/2002WO2002076504A1 Remedies for inflammatory bowel diseases
10/03/2002WO2002076501A2 Blood cell production via activation of the hemoglobin scavenger receptor
10/03/2002WO2002076499A2 Combination treatment of pancreatic cancer
10/03/2002WO2002076486A2 Histidine-rich glycoprotein
10/03/2002WO2002076484A2 Combination of a taxane and a cyclin-dependent kinase inhibitor
10/03/2002WO2002076482A2 USE OF IKK-β INHIBITORS AND METHOD FOR DISCOVERY OF SAID INHIBITORS
10/03/2002WO2002076478A1 Bioactivity of methyl palmitate obtained from a mangrove plant salvadora persica l
10/03/2002WO2002076476A2 Prodrugs of anticancer agents employing substituted aromatic acids
10/03/2002WO2002076459A1 Method and dosage form for treating tumors by the administration of tegafur, uracil, folinic acid, paclitaxel and carboplatin
10/03/2002WO2002076457A1 Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity
10/03/2002WO2002076454A1 Method for treatment of cancer and compositions for use therein
10/03/2002WO2002076450A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/03/2002WO2002076446A1 Esmolol formulation
10/03/2002WO2002076438A2 Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis
10/03/2002WO2002076437A2 Methods for treating neurodegenerative diseases including alzheimer's
10/03/2002WO2002076434A2 Nicotinic receptor agonists for the treatment of inflammatory diseases
10/03/2002WO2002076404A2 Fatty alcohol drug conjugates
10/03/2002WO2002076402A2 Fatty amine drug conjugates
10/03/2002WO2002076395A2 Agents and methods for treatment of cancer
10/03/2002WO2002076390A2 Methods for treating stress disorders using glucocorticoid receptor-specific antagonists
10/03/2002WO2002076388A2 Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting gm1-ganglioside
10/03/2002WO2002076376A2 A stable pharmaceutical composition of pravastatin
10/03/2002WO2002062794A3 Compounds
10/03/2002WO2002062784A8 Piperidinee derivatives as neurokinin 1 antagonists
10/03/2002WO2002062293A3 Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof
10/03/2002WO2002059153A3 Anticoagulants and their uses
10/03/2002WO2002059127A3 Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists
10/03/2002WO2002057248A3 Inhibitors of cruzipain and other cysteine proteases
10/03/2002WO2002046226A3 Trefoil factor 2 (tff2) peptides with moiety attached to asn15
10/03/2002WO2002030942A3 Anhydro sugar derivatives of indolocarbazoles
10/03/2002WO2002030941A3 Topoisomerase inhibitors
10/03/2002WO2002022677A3 Variants of allergenic proteins of the group 2 of dermatophagoides
10/03/2002WO2002014349A3 Non-covalent inhibitors of urokinase and blood vessel formation
10/03/2002WO2002012188A3 Indole compounds useful for the treatment of cancer
10/03/2002WO2001098515A3 Gene-regulating conjugates
10/03/2002WO2001096388A3 Compositions and methods for the therapy and diagnosis of colon cancer
10/03/2002WO2001089543A3 Use of proanthocyanidins as an active ingredient of a stimulator and l-arginine or its salts as a source of nitric oxide to relieve symptoms of erectile dysfuntion
10/03/2002WO2001087306A8 Compositions and methods for the treatment of colorectal cancer
10/03/2002WO2001071004A3 Proteases
10/03/2002WO2001023385A9 Novel tropane analogs
10/03/2002WO2000069896A9 Molecular interactions in haematopoietic cells
10/03/2002WO1998036745A3 Use of polyunsaturated fatty acids for reducing the incidence of necrotizing enterocolitis
10/03/2002US20020143191 Novel stabilized activated derivatives of carbamic acid, their process of preparation and their use for the preparation of ureas
10/03/2002US20020143155 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory defects
10/03/2002US20020143145 Detcting moduators of binding activity of preferential membrane proteins; obtain animal, incubate with modulator, monitor adjustment in activity from recptors
10/03/2002US20020143141 Cyclic peptide for use in the treatment of eating disorders
10/03/2002US20020143069 For therapy of polymorphoneutrophil (PMN) inflammation
10/03/2002US20020143056 As inactivator of antigen- specific T cells is useful in the prophylaxis or therapy of autoimmune diseases, disorders involving an autoimmune component or neoplastic diseases
10/03/2002US20020143053 Carbamate compounds for use in preventing or treating anxiety disorders
10/03/2002US20020143045 Reacting 4-(oxiran-2-ylmethoxy)-9H- carbazole with 2-(2-methoxyphenoxy)ethylamine to produce carvedilol
10/03/2002US20020143043 For therapy and prophylaxis of rheumatoid arthritis, or of allergic disorders, asthma, inflammation; inhibitors of the adhesion and migration of leucocytes and/or antagonists of adhesion receptor VLA-4 belonging to the integrins group
10/03/2002US20020143040 Having antipyretic action, analgesic action, anti-inflammatory action;side effect reduction
10/03/2002US20020143032 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
10/03/2002US20020143029 Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity
10/03/2002US20020143027 As inhibitors of tumor necrosis factor; for therapy of cachexia, arthritis, rheumatoid arthritis, osteoarthritis, reperfusion injury, congestive heart failure, Crohn's disease, ulcerative colitis, systemic lupus erythrematosis
10/03/2002US20020143020 Novel piperazine derivatives
10/03/2002US20020143017 Pyridazinone aldose reductase inhibitors
10/03/2002US20020143014 Aryl and heteroaryl substituted tetrahydroisoquinolines and use thereof
10/03/2002US20020143011 Tri-substituted phenyl derivatives and processes for their preparation
10/03/2002US20020143010 Compounds for treating fibromyalgia and chronic fatigue syndrome
10/03/2002US20020143008 CRF receptor antagonists and methods relating thereto
10/03/2002US20020143004 Allosteric adenosine receptor modulators
10/03/2002US20020142996 Use of bisphosphonic acids for treating angiogenesis
10/03/2002US20020142991 Treating or preventing drug toxicity using a toxicity reducing amount of N-acetylcysteine
10/03/2002US20020142990 Locally administering to a human an axon of neuron therapeutically effective amount of activator of cyclic nucleotide dependent protein kinase, whereby growth of axon is promoted; detecting a resultant growth promotion of axon
10/03/2002US20020142986 Used in the diagnosis or prognosis of liver associated disorders
10/03/2002US20020142985 Therapeutic compositions and methods of treating glycolipid storage related disorders
10/03/2002US20020142984 Administering a positively charged liposome to animal, wherein positively charged liposome is associated with nucleic acid molecule, wherein nucleic acid molecule is in operable association with a promoter
10/03/2002US20020142968 For therapeutic and/or prophylactic treatment of idiopathic and adult respiratory distress syndrome, pulmonary fibrosis following treatment with radiation or chemotherapy, septic shock, septicemia, inflammatory responses
10/03/2002US20020142966 For cancer therapy
10/03/2002US20020142962 Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs
10/03/2002US20020142956 Administering an agent which triggers anion efflux in respiratory tissue via the activation of a secretin receptor for therapy of cystic fibrosis
10/03/2002US20020142950 Methods for enhancing the bioavailability of a drug
10/03/2002US20020142941 Intraductal treatment targeting methylated promoters in breast cancer
1 ... 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 ... 1564